Aprogen pharmaceuticals,Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was KRW 15,226.84 million compared to KRW 15,159.66 million a year ago. Net income was KRW 3,092.06 million compared to KRW 1,691.6 million a year ago. Basic earnings per share from continuing operations was KRW 8 compared to KRW 4 a year ago. Diluted earnings per share from continuing operations was KRW 8 compared to KRW 4 a year ago. Basic earnings per share was KRW 8 compared to KRW 4 a year ago.
For the six months, sales was KRW 24.92 million compared to KRW 353.12 million a year ago. Net income was KRW 5,918.22 million compared to KRW 3,636.68 million a year ago. Basic earnings per share from continuing operations was KRW 15 compared to KRW 9 a year ago. Diluted earnings per share from continuing operations was KRW 15 compared to KRW 9 a year ago. Basic earnings per share was KRW 15 compared to KRW 9 a year ago.